α2-and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity

Psychopharmacology

Volumn 222, Issue 2, 2012, Pages 237-245

  Roychowdhury, Swagata ^a   Peña Contreras, Zulma ^a,b   Tam, Jason ^a   Yadlapalli, Amulya ^a   Dinh, Lu ^a   Nichols, Justin Andrew ^a,c   Basu, Debarshi ^a   Atzori, Marco ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alpha 2 adrenoceptors; Auditory; Beta adrenoceptors; Impulsivity; Norepinephrine; Nortriptyline; Operant chamber; Rat; Response latency; Sustained attention

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; NORTRIPTYLINE; PRAZOSIN; PROPRANOLOL; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; AUDITORY STIMULATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; IMPULSIVENESS; LATENT PERIOD; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME; TASK PERFORMANCE;

EID: 84864492354     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2635-y     Document Type: Article

References (63)

1. Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ (2007) Beta-adrenergic modulation of cognitive flexibility during stress. J Cogn Neurosci 19:468-478
2. Aoki C, Venkatesan C, Go CG, Forman R, Kurose H (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:266-277
3. Arnsten AF (1998) Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2: 436-47
4. Arnsten AFT, Goldman-Rakic PS (1984) Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res 306:9-18
5. Arnsten AFT, Goldman-Rakic PS (1985) Catecholamines and cognitive decline in aged nonhuman primates. Ann N Y Acad Sci 444:218-234
6. Arnsten AFT, Li BM (2005) Neurobiology of executive functions: Catecholamine influences of prefrontal cortical functions. Biol Psychiatry 57:1377-1384
7. Arnsten AF, Steere JC, Hunt RD (1996) The contribution of a2- noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry 53:448-455
8. Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309-1320
9. Aston-Jones G, Iba M, Clayton E, Rajkowski J, Cohen J (2007) The locus coeruleus and regulation of behavioral flexibility and attention: Clinical implications. In: Ordway GA, Schwartz MA, Frazer A (eds) Brain norepinephrine: Neurobiology and therapeutics. Cambridge University Press, Cambridge, pp 196-235
10. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94
11. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84
12. Biederman J, Spencer T (1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242
13. Brennan AR, Arnsten AFT (2008) Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function. Ann N Y Acad Sci 1129:236-245
14. Bruno KJ, Hess EJ (2006) The a2C-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder (2006). Neurobiol Dis 23:679-688
15. Bushnell PJ (1998) Behavioral approaches to the assessment of attention in animals. Psychopharmacology 138:231-259
16. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380
17. Cole SO, Michaleski A (1986) Dose-dependent impairment in the performance of a go-no go successive discrimination by chlordiazepoxide. Psychopharmacology 88:184-186
18. Dagnino-Subiabre A, Munoz-Llancao P, Terreros G, Wyneken U, Díaz-Véliz G, Porter B, Kilgard MP, Atzori M, Aboitiz F (2009) Chronic stress induces dendritic atrophy in the rat medial geniculate nucleus: Effects on auditory conditioning. Behav Brain Res 203:88-96
19. Dahlström A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system: Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl 232:1-55
20. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates. Neurosci Biobehav Rev 28:771-784
21. Dekeyne A, Gobert A, Auclair A, Girardon S, Millan MJ (2002) Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors. Psychopharmacology 162:156-167
22. del Campo N, Chamberlain SR, Sahakian BR, Robbins TW (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 69:145-157
23. Devilbiss DM, Berridge CW (2006) Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J Pharmacol Exp Ther 319:1327-1335
24. Donovan E (2010) Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: Forgetting therapy revisited. Perspect Biol Med 53:61-74
25. Dubocovich ML (1984) Presynaptic alpha-adrenoceptors in the central nervous system. Ann N Y Acad Sci 430:7-25
26. Floody OR, Kilgard MP (2007) Differential reductions in acoustic startle document the discrimination of speech sounds in rats. J Acoust Soc Am 122:1884-1887
27. Franowicz JS, Arnsten AFT (1998) The a2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacology 136:8-14
28. Frazer A (2001) Serotonergic and noradrenergic reuptake inhibitors: Prediction of clinical effects and in vitro potencies. J Clin Psychiatry 12:16-23
29. Gamo NJ, Wang M, Arnsten AF (2010) Methylphenidate and atomoxetine enhance prefrontal function through a2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49:1011-1023
30. Grilly DM, Gowans GC (1988) Effects of naltrexone, d-amphetamine, and their interaction on the stimulus control of choice behavior of rats. Psychopharmacology 96:73-80
31. Haapalinna A, Viitamaa T, MacDonald E, Savola JM, Tuomisto L, Virtanen R, Heinonen E (1997) Evaluation of the effects of a specific a2-adrenoceptor antagonist, atipamezole, on a1-and a2- adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn Schmiedebergs Arch Pharmacol 356:570-582
32. Heal DJ, Smith SL, Kulkarni RS, Rowley HL (2008) New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 90:184-197
33. Jodo E, Aston-Jones G (1997) Activation of locus coeruleus by prefrontal cortex by excitatory amino acid inputs. Brain Res 768:327-332
34. Koskinen T, Haapalinna A, Sirvif J (2003) a-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92:214-225
35. Li BM, Mei ZT (1994) Delayed-response deficit induced by local injection of the alpha-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav Neural Biol 62:134-139
36. Liu YP, Lin YL, Chuang CH, Kao YT, Chang ST, Tung CS (2009) Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task. J Biomed Sci 16:72-83
37. Lovejoy DW, Ball JD, Keats M, Stutts ML, Spain EH, Janda L, Janusz J (1999) Neuropsychological performance of adults with attention deficit hyperactivity disorder (ADHD): Diagnostic classification of estimates for measures of frontal lobe/executive functioning. J Int Neuropsychol Soc 5:222-233
38. McGaughy J, Sarter M (1995) Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117:340-357
39. Merriam AE (2000) Tricyclic antidepressants. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Oxford University Press, New York, pp 1203-1206
40. Milstein JA, Lehmann O, Theobald DE, Dalley JW, Robbins TW (2007) Selective depletion of cortical noradrenaline by antidopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat. Psychopharmacology 190:51-63
41. Milstein JA, Dalley JW, Robbins TW (2008) Methylphenidate-induced impulsivity: Pharmacological antagonism by β-adrenoceptor blockade. J Psychopharmacol 24:309-321
42. Mirsky AF, Duncan CC (2001) A nosology of disorders of attention. In: Wasserstein J, Wolf LE, Lefever FF (eds) Adult attention deficit disorder: Brain mechanisms and life outcomes. The New York Academy of Sciences, New York, pp 17-32
43. Mishima K, Fujii M, Aoo N, Yoshikawa T, Fukue Y, Honda Y, Egashira N, Iwasaki K, Shoyama Y, Fujiwara M (2002) The pharmacological characterization of attentional processes using two-lever reaction time task in rats. Biol Pharm Bull 25:1570-1576
44. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41
45. O'Donnell JM, Seiden LS (1983) Differential-reinforcement-of-lowrate 72-second schedule: Selective effects of antidepressant drugs. J Pharmacol Exp Ther 224:80-88
46. Pattij T, Schetters D, Schoffelmeer AN, van Gaalen MM (2011) On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacology 219:327-420
47. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, Cahill L, Orr SP (2002) Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51:189-192
48. Pliszka SR, McCracken JT, Maas JW (1996) Catecholamines in attention-deficit hyperactivity disorders: Current perspectives. J Am Acad Child Adolesc Psychiatry 35:264-272
49. Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ (2000) A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 10:193-204
50. Ramos BP, Arnsten AFT (2007) Adrenergic pharmacology and cognition: Focus on the prefrontal cortex. Pharmacol Ther 113:523-536
51. Robbins TW (2002) The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
52. Sagvolden T (2006) The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of attention-deficit/hyperactivity disorder. Behav Brain Funct 2:41
53. Schubert J, Nybäck H, Sedvall G (1970) Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. J Pharm Pharmacol 22:136-139
54. Sessions GR, Kant GJ, Koob GF (1976) Locus coeruleus lesions and learning in the rat. Physiol Behav 17:853-859
55. Sonuga-Barke EJ (2005) Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231
56. Tait DS, Brown VJ, Farovik A, Theobald DE, Dalley JW, Robbins TW (2007) Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. Eur J Neurosci 25:3719-3724
57. Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems of the noradrenergic neurons of rat brain. Naunyn Schmiedebergs Arch Pharmacol 299:123-141
58. Vaiva G, Ducrocq F, Jezequel K, Averland B et al (2003) Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 54:947-949
59. Valsamis B, Schmid S (2011) Habituation and prepulse inhibition of acoustic startle in rodent. J Vis Exp 55:e3446
60. Wilens TE, Biederman J, Spencer T, Geist DE (1993) A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry 32:270-277
61. Wong CC, Mill J, Fernandes C (2011) Drug and addiction: An introduction to epigenetics. Addiction 106:480-489
62. Zhang HT, Whisler LR, Huang Y, Xiang Y et al (2009) Postsynaptic a2-adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology 34:1067-1077
63. Zhu J, Spencer TJ, Liu-Chen LY, Biederman J, Bhide PJ (2011) Methylphenidate and μ opioid receptor interactions: A pharmacological target for prevention of stimulant abuse. Neuropharmacology 61:283-292